Aurobindo launches ‘Molnaflu’ oral Covid drug
Hyderabad, Jan 6 : Aurobindo Pharma Limited, an integrated global pharmaceutical company headquartered in Hyderabad, Today announced it has launched its brand Molnupiravir - 'Molnaflu’- , a oral Covid drug for treatment of adult patients,…